Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Mazen Darwazah. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. Cumulatively, 16 reports have been logged. History available since 30 April 2025. The latest transaction was disclosed on 19 December 2025 (Purchase). Regulator: RNS (LSE). All data is free.
Companies and markets linked to Mazen Darwazah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Mazen Darwazah has made 16 filings in total, all concerning Hikma Pharmaceuticals PLC, where he is Executive Vice Chairman and Deputy CEO, MENA. In the 16 sampled filings from 2024-03-13 to 2026-06-05, they are purchases, with a total stated amount of EUR 11739041 and no sales.